To view this email as a web page, click here.
 
BLADDER CANCER
 
How has FDA label change affected treatment of advanced bladder Ca
Findings from a study investigating treatment utilization for advanced bladder cancer patients indicate that physicians are doing a good job responding to incoming safety data.
Learn more
ADVERTISEMENT
 
Untreated MIBC has short natural course, significant morbidity
Patients deemed unfit for curative treatment still required two to three surgical interventions, according to a recent study.
Read Dr. Mian’s column
 
MORE FROM UROLOGY TIMES
 
Bladder Ca biomarkers and BCG: New knowledge of the urinary microbiome
DDR mutations linked to improved urothelial cancer outcomes
ADVERTISEMENT
Are you sure it’s really a Blue Light Cystoscopy?
Marketplace confusion is running high. Be sure you know the facts about the Blue Light Cystoscopy that the 2016 AUA/SUO Guideline says should be used (Moderate Recommendation, Grade B). Read the Guideline statement and more.
 
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.